This pipeline uses various statistical tests to identify mRNAs whose expression levels correlated to selected clinical features.
Testing the association between 17911 genes and 7 clinical features across 33 samples, statistically thresholded by Q value < 0.05, 5 clinical features related to at least one genes.
-
1 gene correlated to 'AGE'.
-
KRT6B|3854
-
5 genes correlated to 'GENDER'.
-
EDA|1896 , PPARGC1A|10891 , NLGN4Y|22829 , PRKY|5616 , TMED4|222068
-
3 genes correlated to 'DISTANT.METASTASIS'.
-
ZNF689|115509 , MARCH8|220972 , TNPO3|23534
-
6 genes correlated to 'COMPLETENESS.OF.RESECTION'.
-
MARCH8|220972 , ZNF689|115509 , TNPO3|23534 , MAPK8|5599 , MGRN1|23295 , ...
-
3 genes correlated to 'NEOPLASM.DISEASESTAGE'.
-
L3MBTL4|91133 , MARCH8|220972 , THNSL2|55258
-
No genes correlated to 'Time to Death', and 'LYMPH.NODE.METASTASIS'.
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=0 | ||||
AGE | Spearman correlation test | N=1 | older | N=1 | younger | N=0 |
GENDER | t test | N=5 | male | N=2 | female | N=3 |
DISTANT METASTASIS | ANOVA test | N=3 | ||||
LYMPH NODE METASTASIS | t test | N=0 | ||||
COMPLETENESS OF RESECTION | ANOVA test | N=6 | ||||
NEOPLASM DISEASESTAGE | ANOVA test | N=3 |
Time to Death | Duration (Months) | 0.1-83.6 (median=19.8) |
censored | N = 12 | |
death | N = 17 | |
Significant markers | N = 0 |
AGE | Mean (SD) | 59.4 (18) |
Significant markers | N = 1 | |
pos. correlated | 1 | |
neg. correlated | 0 |
SpearmanCorr | corrP | Q | |
---|---|---|---|
KRT6B|3854 | 0.95 | 0 | 0 |
GENDER | Labels | N |
FEMALE | 10 | |
MALE | 23 | |
Significant markers | N = 5 | |
Higher in MALE | 2 | |
Higher in FEMALE | 3 |
T(pos if higher in 'MALE') | ttestP | Q | AUC | |
---|---|---|---|---|
EDA|1896 | -6.98 | 8.388e-08 | 0.00149 | 0.9565 |
PPARGC1A|10891 | -6.39 | 4.098e-07 | 0.00726 | 0.9522 |
NLGN4Y|22829 | 11.05 | 9.292e-07 | 0.0165 | 1 |
PRKY|5616 | 14.16 | 1.216e-06 | 0.0215 | 1 |
TMED4|222068 | -5.82 | 2.59e-06 | 0.0459 | 0.9478 |
DISTANT.METASTASIS | Labels | N |
M0 | 22 | |
M1 | 1 | |
MX | 10 | |
Significant markers | N = 3 |
ANOVA_P | Q | |
---|---|---|
ZNF689|115509 | 6.031e-09 | 0.000108 |
MARCH8|220972 | 9.157e-08 | 0.00164 |
TNPO3|23534 | 2.08e-07 | 0.00373 |
LYMPH.NODE.METASTASIS | Labels | N |
N0 | 24 | |
NX | 8 | |
Significant markers | N = 0 |
COMPLETENESS.OF.RESECTION | Labels | N |
R0 | 18 | |
R1 | 6 | |
R2 | 1 | |
RX | 6 | |
Significant markers | N = 6 |
ANOVA_P | Q | |
---|---|---|
MARCH8|220972 | 3.319e-08 | 0.000594 |
ZNF689|115509 | 8.656e-08 | 0.00155 |
TNPO3|23534 | 2.004e-07 | 0.00359 |
MAPK8|5599 | 7.24e-07 | 0.013 |
MGRN1|23295 | 1.454e-06 | 0.026 |
AP2A1|160 | 2.778e-06 | 0.0497 |
NEOPLASM.DISEASESTAGE | Labels | N |
STAGE I | 10 | |
STAGE II | 5 | |
STAGE III | 2 | |
STAGE IIIA | 7 | |
STAGE IIIB | 1 | |
STAGE IVB | 1 | |
Significant markers | N = 3 |
ANOVA_P | Q | |
---|---|---|
L3MBTL4|91133 | 6.568e-07 | 0.0118 |
MARCH8|220972 | 1.672e-06 | 0.0299 |
THNSL2|55258 | 1.776e-06 | 0.0318 |
-
Expresson data file = LIHC-TP.uncv2.mRNAseq_RSEM_normalized_log2.txt
-
Clinical data file = LIHC-TP.clin.merged.picked.txt
-
Number of patients = 33
-
Number of genes = 17911
-
Number of clinical features = 7
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.